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Introduction
The substantia gelatinosa (SG; layer II) of the spinal cord is an important area of sensory integration in the CNS, where incoming C and A  fibre axons of the primary afferents innervate local interneurons, which process nociceptive information to ascending projection neurons originating in the layer I of the spinal cord (Furue et al., 2004; Gu and Heft, 2004) . The SG receives dense descending inhibitory serotonergic and noradrenergic inputs from the raphe magnus and locus coeruleus; the afferent terminals and interneurons contain excitatory substances such as substance P and calcitonin gene related peptide; high densities of excitatory and inhibitory interneurons in the SG utilize glutamate as excitatory and glycine/GABA as inhibitory transmitters (Brown, 1982; Furue et al., 2004) . Many of these neuronal transmitters/modulators, including the endogenous nucleoside adenosine may regulate SG functions as shown by the patch clamp technique in spinal cord slice preparations (Lalo et al., 2004) .
Adenosine is an active metabolite of the neuronal/glial signaling molecule ATP, which via various types of P2X receptors is involved in the processing and modulation of painful stimuli i.e. at the level of the spinal cord (Burnstock and Wood, 1996; Wirkner et al., 2007b; Burnstock et al., 2011) . P2X3 receptors located at the terminals of primary sensory afferents forming synapses with dorsal horn neurons of the SG (Nakatsuka et al., 2003) facilitate the release of the neurotransmitter glutamate and thereby enforce pain transmission (Gu and MacDermott, 1997) . In addition, during neuropathic pain, astrocytic P2X7 and microglial P2X4/P2X7 receptors lead to the release of inflammatory mediators causing hyperalgesia and allodynia (Tsuda et al., 2005; Burnstock et al., 2011) . P2X7 receptors have originally been identified at peripheral and central immunocytes such as macrophages, lymphocytes and microglia, where they mediate immediate necrosis and on a longer term either apoptosis or cell proliferation (Sperlágh et al., 2006) . Although there is broad consensus that macroglial cells possess P2X7 receptors (Verkhratsky et al., 2009; Franke et al., 2012) , there is an 5 ongoing dispute on the question whether this receptor-type is also present at peripheral and central neurons (Sim et al., 2004; Anderson and Nedergaard, 2006) .
The classic signaling mechanism of the P2X7 receptor-channels opened by pathologically high ATP concentrations involves the sustained elevation of the intracellular free Ca 2+ , several second messengers and enzyme cascades due to the drastic change in intracellular ion homeostasis, and the release of interleukin-1/nitric oxide (NO)/reactive oxygen species (ROS) (Sperlágh et al., 2006; Skaper et al., 2010) .
The questions we attempted to answer by the present study were the following: (1) Do spinal astrocytes in agreement with the supraspinal ones possess functional P2X7 receptors? (2) Do SG neurons respond to P2X7 receptor agonists directly or indirectly via signaling molecules secreted from neighbouring astrocytes? (3) Does astrocytic ROS modify the sensitivity of SG neurons to P2X7 receptor agonists? We tentatively suggest that spinal astrocytes contain P2X7 receptors whose activation leads to a release of glutamate and ROS which induce and facilitate, respectively, the ensuing current responses in neurons.
Materials and Methods

Brain slice preparation, whole-cell patch clamp recordings, and drug application protocols
Wistar rat pups (11-14 days old) and in some cases transgenic mice expressing mRFP1 under the control of the human glial fibrillary acidic promoter (Tg(GFAP/mRFP1); 10-14 days old) were decapitated in order to prepare slices of their thoracolumbar spinal cord (Luo et al., 2002) . The transgenic mice were a generous gift from Dr. Petra G. Hirrlinger (Paul-Flechsig-Institut für Hirnforschung, University of Leipzig) (Hirrlinger et al., 2005) . All experiments were in accordance with the German guidelines for the use of animals in biomedical research. After decapitation, ventral laminectomy, followed by dorsal and ventral root transsection 6 and in situ meninges removal was performed. The spinal cord was taken out and placed in ice-cold, oxygenated (95% O 2 plus 5% CO 2 ) artificial cerebrospinal fluid (aCSF) of the following composition (mM): NaCl 126, KCl 2.5, CaCl 2 2.4, MgCl 2 1.3, NaH 2 PO 4 1.2, NaHCO 3 25, and glucose 11; pH 7.4). Transverse slices with a nominal thickness of 200 m were cut from a piece of the lumbosacral spinal cord by using a vibratome (VT1200, Leica Biosystems). The slices were incubated for 30 min at 37°C in continuously aerated (95% O 2 plus 5% CO 2 ) aCSF. A single slice was placed in a recording chamber and superfused with oxygenated aCSF at room temperature (20) (21) (22) (23) (24) o C) at a speed of 3 ml/min. The composition of the aCSF used for superfusion was identical with that used for incubation. To create low divalent cation (low X 2+ ) conditions, MgCl 2 was omitted from the medium and the CaCl 2 concentration was decreased to 0.5 mM.
Whole-cell patch clamp recordings were made after at least 60 min of superfusion with normal or low X 2+ aCSF either from neurons or astrocytes of the SG of the spinal cord. Both types of cells were visualized with an upright interference contrast microscope and a x40 water immersion objective (Axioscope FS, Carl Zeiss).
Astroglial cells of Tg(GFAP/mRFP1) mice were identified by means of an appropriate fluorescence filter of our microscope. Patch pipettes were produced by a horizontal micropipette puller (P-97, Sutter Instruments) from borosilicate capillaries. They were filled with intracellular solution of the following composition (mM): K-gluconic acid 140, MgCl 2 1, HEPES 10, EGTA 11, Mg-ATP 1.5, Li-GTP 0.3, and Lucifer Yellow (LY) 0.1; pH 7.3. Pipette resistances were in the range of 5-7 M.
The SG was clearly discernible as a relatively translucent band across the dorsal horn, somewhat below the surface of the spinal cord (Fig. 1Aa) . After being filled with LY, fluorescence microscopy showed that neurons had round and sharply edged contours (Fig. 1Ab , upper panel), whereas astrocytes possessed many bushy processes (Fig. 1Ab, Step duration was 500 ms, and steps were delivered with an interval of 2 s. Cells where the series resistance (R s ) varied more than 20% during the experiments were discarded; there was no compensation for the R s before recording was started.
Multiclamp and pClamp software (Molecular Devices) were continuously used to store the recorded data, to perform offline analysis/filtering and to trigger the application system used. All compounds were pressure-injected locally by means of a computer-controlled DAD12 superfusion system (Adams and List). The drug application tip touched the surface of the brain slice and was placed 100-150 m from the patched cell. Agonists were applied every 5 min for 10 s each, either at increasing (e.g. Fig. 2Aa , b) or stable concentrations (e.g. Fig. 1Bc , Ca, Da). When the interaction of Bz-ATP with excitatory amino acid (EAA), GABA A , or P2X7 receptor 8 antagonists was studied, a stable concentration of Bz-ATP was applied with the usual protocol before (S 1 , S 2 ), during (S 3 , S 4 ) and after superfusion (S 5 , S 6 ) with these antagonists for 10 min (e.g. Fig. 3A-G) . When the interaction of Bz-ATP with H 2 O 2 , Nacetyl-L-cysteine (NAC) and catalase was studied, Bz-ATP was applied with a slightly modified protocol before, during and after superfusion with the ROS modulators (e.g. Fig. 5A-D) . H 2 O 2 , NAC or catalase were applied 5 min after the first application of Bz-ATP (at S 2 ), and were left in the superfusion medium for 10 min in total. Thus, 10 min elapsed between the first and second Bz-ATP injection (S 1 , S 3 ), whereas only 5 min elapsed between the second and third Bz-ATP injection (S 3 , S 4 ).
Eventually, the protocol used to study the facilitation of Bz-ATP or ATP effects by a low X 2+ medium, differed from the above standard procedure in that low X 2+ was superfused for 10 min after S 2 before the P2X7 receptor agonists were applied at S 3 for 10 s. Excised patches were prepared by slowly withdrawing the pipette and thereby separating the patch from the surrounding cells.
In some of the experiments, hippocampal slices of rats were prepared by procedures described earlier (Leichsenring et al., 2013) . Whole-cell patch clamp recordings were made either from neurons of the CA1 region, or astrocytes from the oriens region in close apposition to CA1 (200 m distance). Compositions of the extra-and intracellular media were identical with those used for SG neurons and astrocytes. All further experimental conditions, including cell-type identification, recording arrangements, drug application protocols, and evaluation procedures were also similar. Biomedical) with sensing tips of 50 µm in diameter and 0.5 mm in length. The surface of the ROS biosensors were deposited with superoxide dismutase and catalase enzymes to break down reactive oxygen species and served as interference controls to NULL sensors, which lacked these reductive enzymes. The net signal difference (NULL minus ROS) were calculated, and calibration curves ( Figure 6A ) were used to obtain relevant concentrations of in situ ROS.
Bz-ATP (300 µM) was superfused for 2 min. When applied, the P2X7 antagonist A-438079 (10 µM) was pre-perfused for 10 min before BzATP stimulation. Using the calibration curve constructed from the net signal of known H 2 O 2 concentrations ranging from 1-10 M ( Figure 6A , inset), the maximal increases evoked by the drug treatments were read of at their peaks and were expressed in µM H 2 O 2 equivalents.
In 2 out of 8 slices (BzATP), and 1 out of 6 slices (BzATP plus A-438079) the treatments did not evoke detectable ROS release (no increase in net signal compared to baseline, therefore yielding negative maximal values); these values
were not included in analysis.
Immunofluorescence and confocal microscopy
Rats were transcardially perfused under anesthesia with paraformaldehyde (2%) in sodium acetate buffer (pH 6.5; solution A) followed by paraformaldehyde (2%) in sodium borate buffer (pH 8.5; solution B) (Franke et al., 2004) . Then, the brains were removed, stored overnight in solution B and 50 µm coronal sections of their hippocampal formation and the spinal cord containing the substantia gelatinosa were prepared using a vibratome (Leica). In some cases, spinal cord slices (100 µm thickness), kept in oxygenated aCSF for 2-3 h, similar to those used for 10 electrophysiological recordings, were processed for immunohistochemical investigations.
50 µm thick brain slices from transcardially perfused brains were incubated with antibody mixtures of rabbit anti-P2X7 (1:600; Alomone Labs) and/or with mouse anti-GFAP (1:1,000; glial fibrillary acidic protein; Santa Cruz), or mouse anti-S100
(1:600, S100 Protein Ab-1, Clone 4C4.9; Dianova), mouse anti-MAP2 (1:1,000; microtubule associated protein; Chemicon), as well as goat anti-Iba1 (1:50; goat polyclonal to Iba1; abcam) together with 0.3% Triton X-100 and 5% FCS in trisbuffered saline (TBS) for 48 h at 4°C.
For the simultaneous visualisation of the different primary antibodies, mixtures of secondary antibodies specific for the appropriate species IgG (rabbit, mouse, goat)
were applied. Carbocyanine (Cy)2-(1:400), Cy3-(1:1000), Cy5-(1:100) conjugated
IgGs (all from Jackson ImmunoResearch) diluted in 0.3% Triton X-100 and 5% fetal calf serum (FCS) in TBS were applied, respectively, for 2 hours at room temperature.
Control experiments were performed without all primary antibodies or by preadsorption of the antibody with the immunizing peptides. After mounting on glass slides, all stained sections were dehydrated in a series of graded ethanol, processed through n-butylacetate and coverslipped with Entellan (Merck).
The double and triple immunofluorescences were investigated by a confocal laser scanning microscope (LSM 510 Meta, Carl Zeiss) using excitation wavelengths of 633 nm (helium/neon2, blue Cy5-labelling), 543 nm (helium/neon1, red Cy3-immunofluorescence) and 488 nm (argon, yellow-green Cy2-immunofluorescence).
Materials
The following drugs were used: adenosine 5′-triphosphate disodium salt hydrate
gabazine, muscimol (Tocris Bioscience). The pH value of the ATP-containing aCSF superfused onto the neurons/astrocytes was adjusted by NaOH to 7.4.
Statistics
Concentration-response curves for agonists were fitted by using a three parametric Hill plot (SigmaPlot 11.0, SPSS). MeansS.E.M. are given throughout. SigmaPlot 11.0 was used for statistical evaluation. Multipile comparisons between data were performed by one way analysis of variance followed by the Holm-Sidak test. Two data sets were compared by using the Student's t-test or the Mann-Whitney RankSum test as appropriate. In all cases, a probability level of 0.05 or less was considered to be statistically significant.
Results
Current responses induced by Bz-ATP/ATP, glutamate, and GABA in astrocytes and neurons of the rat spinal cord substantia gelatinosa; mediation of ATP effects by P2X7 receptors
Initially the cell type recorded from (astrocyte or neuron) was identified. There was no discrimination between the different astrocytes described e.g. for the prefrontal cortex or the hippocampal oriens layer (outwardly rectifying, variably rectifying, passive; classification based on the current/voltage characteristics; e.g. Oliveira et al., 2011; Leichsenring et al., 2013) , which were also present in the SG. In addition,
we did not characterize the various types of neurons described for the SG (phasic, tonic, irregular, delay, transient; classification on the basis of the firing pattern and morphological properties; e.g. Grudt and Perl, 2002) .
It was an important point to decide whether recordings are from astrocytes or microglia. Microglial cells in brain slices may exhibit morphological characteristics 12 somewhat similar to astroglia after LY filling and also fail to fire action potentials in response to depolarizing current injection (Fig. 1Ab, lower panel; compare Fig. 1Ba with Bb) (Boucsein et al., 2000) . However, in voltage-clamp recordings, resting microglia express a typical inwardly rectifying current pattern and acquire an additional outwardly rectifying current component only after cell activation, for example, following facial nerve axotomy (Boucsein et al., 2000) , ; low X 2+ medium), the effect of Bz-ATP markedly increased. Two subsequent applications of Bz-ATP (300 M) caused reproducible current responses, both in a normal and low X 2+ medium. In addition, the potentiation induced by the lack of divalent cations rapidly reversed after returning to normal X 2+ conditions. We evaluated both the absolute current amplitudes before, during and after superfusion with low X 2+ aCSF (Fig. 1Ca ) and the percentage increase of the Bz-ATP effects from S 2 to S 3 (Fig. 1Cb) .
Similar results were obtained for SG neurons, although in this series of experiments the 2 nd application of Bz-ATP (300 M; S 4 ) in the presence of a low X 2+ medium caused less current than its 1 st application (S 3 ; Fig. 1Da) It is necessary to repeatedly point out that in contrast to SG astrocytes, SG neurons form a very inhomogenous population. The majority of SG neurons are excitatory, while their inhibitory counterparts represent a minority (Santos et al., 2007; Landry et al., 2004) . It was also reported that supposedly glutamatergic, excitatory SG neurons are presynaptically inhibited by opioid µ-receptor agonists, while the inhibitory ones are opioid resistant (Santos et al., 2004) . By contrast, purinergic P2X7 receptor agonists indiscriminately activated SG neurons, irrespective of their firing patterns (present study). However, differences in receptor-sensitivities may explain the large scatter in the current amplitudes.
Then, we tested the effect of the mother compound of Bz-ATP, ATP itself. Once again, ATP (3 mM) produced only small current responses in astrocytes and neurons in a normal aCSF, which however largely increased in the presence of a low X 2+ medium (Fig. 1Ea, b ). In agreement with the Bz-ATP experiments, the low X 2+ extracellular solution appeared to cause a weaker potentiation of the ATP-induced currents in neurons (to 214.248.1%; n=6; P<0.05 from 0%) than in astrocytes (to 426.495.4%; n=5; P<0.05 from 0%), although this difference did not reach the level of statistical significance (Fig. 1Eb) .
In all subsequent experiments, a low X 2+ extracellular medium was used throughout. Increasing concentrations of Bz-ATP (0.03-3 mM) and ATP (0.3-30 mM) (Fig. 2Aa, b) induced inward currents; the plots of the logarithmic agonist concentrations against the current amplitudes yielded the concentration-response curves shown in Fig. 2Ac and d. Both at astrocytes and neurons, Bz-ATP was much more potent than ATP itself. In addition, the maximum current amplitudes for ATP and Bz-ATP were similar at the astrocytes, but not at the neurons. The concentrationresponse curve of ATP at the neurons was much more shallow and reached only a lower maximum than the comparable curve for Bz-ATP did (for the respective EC 50
and E max values see the Legend of Fig. 2Ac, d ).
14 Because ATP is an early neural signaling molecule, we investigated the effects of prototypic excitatory and inhibitory transmitters in SG neurons and astrocytes. AMPA and NMDA were used to stimulate the respective ionotropic glutamate receptors, while muscimol was used to activate the GABA A receptor-channel. AMPA (1-100 M)
elicited astrocytic/neuronal currents of amplitudes depending on the agonist concentration ( Fig. 2Ba-c) . It was absolutely clear that the size of the neuronal currents markedly surmounted that of the astrocytic ones (for the IC 50 and E max values see the Legend to Fig. 2Bc ). Moreover, a near maximum was reached already at 10 M AMPA, without a further relevant change up to 100 M. In separate experiments, 100 M of AMPA, NMDA and muscimol were tested on the same astrocyte or neuron ( Fig. 2Ca-c) . The larger AMPA responses at neurons in comparison with astrocytes could be confirmed also under these conditions and in addition NMDA exhibited the same neuron/astrocyte activity ratio as AMPA (Fig. 2Ca,   b ). In spite of using a Mg
2+
-free (and low Ca 2+ ) medium, which relieves the Mg 2+ -block of the NMDA receptor-channel, NMDA was on both cell-types less active than AMPA. In contrast to the excitatory amino acid agonists, muscimol caused similar current amplitudes at neurons and astrocytes. Eventually, AMPA, NMDA and muscimol acted on all neurons investigated, but only at a subpopulation of astrocytes ( Fig. 2Ca-c) . Out of the total cell number of 9, 2 astrocytes reacted to none of the agonists, and a variably number of cells reacted to 1, 2 or 3 agonists (Fig. 2Cc) .
Hence, in contrast to the astrocyte preferring properties of Bz-ATP and ATP (Fig. 1B-E ), all amino acid transmitters (except muscimol) preferred neurons over astrocytes.
This was evident, when the current amplitudes and/or the proportion of the activated cells were taken into consideration.
Then, we asked ourselves, whether Bz-ATP acts primarily at SG astrocytes (which in other regions of the CNS were repeatedly described to possess P2X7 receptors; Oliveira et al., 2011; Illes et al., 2012) Our assumption, that Bz-ATP activates P2X7 receptors at astrocytes was confirmed in the following series of experiments. In the whole-cell configuration of recording, the highly selective P2X7 receptor antagonist A-438079 (1, 10 M) concentrationdependently inhibited the effect of Bz-ATP (300 M) at astrocytes (Fig. 3Aa, b) , and caused a maximal inhibition already at 1 M in neurons (Fig. 3Ba, b) . No further efforts were undertaken to characterize the P2X receptor-type which mediated the Bz-ATP-sensitive, but A-438079-resistant part of the astrocytic current responses (10 µM A-438079; 18.06.5%; n=10). A comparable residual current was found also in neurons (10 µM A-438079; 25.05.8%; n=10). Bz-ATP is an agonist at most P2X receptor-types (except P2X5 and -6), with particularly high potency at the P2X1,3
receptors (Jarvis and Khakh, 2009 ). However, P2X1 or P2X3 are unlikely to be involved, since the Bz-ATP current did not exhibit desensitization, characteristic for these receptors.
However, Bz-ATP (300 M) induced inward current in excised patches prepared from all astrocytes and neurons investigated. In 4 astrocytes out of a population of 5, A-438079 (10 M) inhibited the small Bz-ATP current to 48.111.4% of its original height (P<0.05); in the residual astrocyte there was no change of the current amplitude at all (100.8%; Fig. 3Ca, b) . Further, in 3 neurons out of a population of 6, A-438079 (10 M) also depressed the tiny Bz-ATP current to 59.86.8% of its original value (P<0.05%), whereas in the residual 3 neurons there was no statistically significant change (122.015.0%; P>0.05; Fig. 3Da, b) . Thus, we confirmed that the majority of SG astrocytes possess P2X7 receptors and so do about one half of the SG neurons as well.
The astrocyte shown in Fig. 3Ea (Fig. 3Eb, B receptors and that the Bz-ATP-induced currents at neurons are due to the effect of this glutamate. The additional involvement of GABA or glycine could not be proven in spite of using the selective antagonists gabazine and strychnine.
Current responses induced by Bz-ATP in CA1 neurons of the hippocampus; mediation of ATP effects by astrocytic P2X7 receptors
In a previous study we reported for astrocytes of the hippocampal oriens layer that P2X7 receptors mediate current responses in a low X 2+ external medium (Oliveira et al., 2011 ). Now we found that neighbouring CA1 neurons also respond to Bz-ATP with inward current in a low Ca 2+ /no Mg 2+ aCSF; such a change in the composition of the normal aCSF led to a sudden increase of the Bz-ATP (300 M) currents ( Fig.   4Aa-c) . A single neuron out of 8 (Fig. 4Aa ) was unresponsive to Bz-ATP in a normal aCSF, whereas the residual 7 neurons exhibited a small current response under these conditions ( Fig. 4Ab, c; 15.34.2 pA; n=7). It is noteworthy that CA1 pyramidal neurons of the hippocampus responded with very different current amplitudes to the same concentration of Bz-ATP when the scatter both within and between individual groups of experiments is taken into consideration (1,495.4995,3 pA, n=7 in Fig.   4Ab ; 2,438.9736.4 pA, n=5 in Fig. 4Bb ; 865.8267.1 pA, n=7 in Fig. 4Cb ).
Repetitive applications of Bz-ATP (300 µM) 5-times did not lead to a statistically significant reduction of the evoked current responses (Fig. 4Ca, b) , although they had a tendency to decrease from S 2 to S 5 . In consequence, we tested the effect of Bz-ATP (300 µM) before, during and after superfusion with A-438079 (10 µM) (Fig. 4Da-b ). The abolition of the agonist effect under these conditions unequivocally proves that P2X7 receptors are involved. It is noteworthy that Bz-ATP-induced currents in 17 hippocampal stratum oriens astrocytes are also due to P2X7 receptor stimulation, as confirmed by investigating the interaction between Bz-ATP and A-438079 (10 µM) (Oliveira et al., 2011) .
Potentiation of neuronal responses to Bz-ATP in the spinal cord substantia gelatinosa but not the hippocampal CA1 area by H 2 O 2
The repetitive application of Bz-ATP (300 M) to SG astrocytes induced stable current amplitudes with no change from the 2 nd to the 5 th application (S 2 -S 5 ; Fig. 5Aa,   b ). In order to avoid any possible variability of the 1 st response, all responses were normalized with respect to the 2 nd Bz-ATP current. No comparable experiments were made to confirm the stability of the effect of Bz-ATP (300 M) at neurons, but there was no reason to assume that repetitive application results in a change of amplitude (see e.g. Fig. 3Ba ). Then, Bz-ATP (300 M) was superfused both in the absence and the presence of H 2 O 2 (100 M) onto astrocytes (Fig. 5Ba, b) and neurons (Fig. 5Bc,   d ). H 2 O 2 did not induce any current on its own, however, strongly potentiated the neuronal, but not astrocytic Bz-ATP currents to 259.673.4% of their original amplitude (n=11; P<0.05). The antioxidant N-acetyl-L-cysteine (NAC; 10 mM) also failed to act by itself; it decreased, however, the Bz-ATP current in neurons (to 51.68.7%; n=8; P<0.05) but not astrocytes (Fig. 5Bb, d) . These results as a whole suggest that exogenous and endogenous ROS facilitate P2X7 receptor-mediated effects only in neurons. Interestingly, catalase (1,000 U/ml), which degrades ROS, failed to alter the Bz-ATP current responses either in neurons or in astrocytes (Fig.   5Bb, d ).
In analogy to the situation in the SG, a combination of AP-5 (50 µM) and CNQX (20 µM) strongly depressed the effect of Bz-ATP (300 µM) in the CA1 region (Fig. 5Ca,   b ). Already AP-5 caused slight inhibition, which was increased by the further addition of CNQX (to 14.24.2%; n=6). Eventually, AP-5, CNQX and gabazine (10 µM)
abolished the Bz-ATP-induced current (to 2.00.5%; n=8; P<0.05 in comparison with 18 AP-5 and CNQX only) (Fig. 5Cd) indicating that both glutamate and GABA are involved in the neuronal responses. However, in contrast to the reaction of SG neurons, the Bz-ATP (300 M) effects in CA1 neurons were insensitive to H 2 O 2 (100 M) and astrocytic currents were even depressed by this agent (Fig. 5Da, b) .
Measurement of the Bz-ATP-induced release of reactive oxygen species from the spinal cord substantia gelatinosa; mediation by P2X7 receptors
Superfusion of SG slices with BzATP (300 µM) for 2 minutes elicited a slow increase of their net ROS production, which was partly reversible upon washout ( Figure 6B ). 
Bz-ATP induced currents in substantia gelatinosa astrocytes of Tg(GFAP/mRFP1) mice
Eventually, a few transgenic Tg(GFAP/mRFP1) mice were used to prove that Bz-ATP (300 µM) induces current responses in GFAP-expressing astrocytes of the SG (Fig.   7 ). The selective P2X7 receptor antagonist A-438079 (10 µM) depressed the Bz-ATP current at S 3 to 12.2±3.0% of its original amplitude (n=8; P<0.05). Because the GFAP-expressing astrocytes were unequivocally identified on the basis of their red fluorescence, recording was without any doubt from this population of astroglia.
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P2X7 receptor-immunoreactivity at microglia, but not at astrocytes or neurons of the substantia gelatinosa
Most experiments were performed on 50 µm thick SG slices, prepared from transcardially perfused rats, where P2X7 receptor-immunoreactivity (IR) was colocalized with the microglial marker Iba1 (Fig. 8Ca-c) , but not the astroglial markers GFAP or S100 ( Fig. 8Aa-c; Fig. 8Ba-c) , or the neuronal marker MAP2 (Fig. 8Da-c) .
We observed in all cases staining for the respective cell-type marker, in the first column of Fig. 8 (a) , staining for P2X7 antibodies in its second column (b) and the merged staining for both types of antibodies in its third column (c).
Immunohistochemistry in the stratum oriens of hippocampal slices resulted in similar results, although the intensity of the staining was lower (not shown). In histological specimens, microglia were in a resting, inactive state as proven by their numerous cellular processes (Fig. 8Ca) . When the same investigations were made on 100 µm thick SG slices superfused with aCSF for 2-3 h, thus, under conditions similar to those used for electrophysiological recordings, the quality of the immunohistochemistry pictures suffered from this treatments (Fig. 8Cci) . The comparison of Fig. 8Cc with Cci shows that microglia was activated by the mechanical damage inflicted upon the living slices by the preparation procedure (round shape, no cellular processes). Microglia and astrocytes established often close spatial relationships.
It remains to be explained why P2X7 receptor-IR was not found on astrocytes in spite of convincing evidence for the presence of functional P2X7 receptors on this cell type (for functional measurements in spinal cord slices of Tg(GFAP/mRFP1 mice see Fig. 7 ). It is a well known fact that e.g. in the hippocampal CA1 area only ~15%
of the astrocytic population stains for GFAP-IR (Bushong et al., 2002) . Therefore, we also used the glial marker S100 for being able to label a partially overlapping population of astrocytes. However, the P2X7-IR was absent in astrocytes stained either for GFAP or S100. Hence, we assume that the low density of such receptors might be a reason for this finding; large Bz-ATP/ATP-induced currents could be 20 demonstrated only in a low X 2+ external medium, which is known to greatly amplify P2X7 receptor function.
Discussion
The main finding of this study is that P2X7 receptors at SG astrocytes and neurons are functionally up-regulated by a low Ca 2+ /no Mg 2+ -containing external medium; it is suggested that these receptors participate in the development of inflammatory and neuropathic pain. In fact, the use of genetically modified mice that lack the P2X7 receptor failed to develop pain following both inflammatory and neuropathic insults (Hughes et al., 2007) . Furthermore, P2X7 receptor antagonists have been shown in animal studies to obliterate such types of chronic pain states Andó et al., 2010) . The loss of P2X7 receptor antagonists to produce an antihyperalgesic effect in interleukin-1 knockout animals (Honore et al., 2009) confirmed that the release of interleukins mediated by P2X7 receptors is a key mechanism in inducing pain during inflammation. Eventually, in humans a genetic association between lower pain intensity and hypofunctional P2X7 receptors was reported to occur (Sorge et al., 2012) .
Of course the above findings do not differentiate between P2X7 receptors at peripheral immunocytes and their counterparts at microglia, astrocytes and possibly neurons in the CNS. It has been reported that astrocyte-like satellite cells in sensory ganglia bear P2X7 receptors, whose activation may lead to the facilitation of painsensing P2X3 receptors at the primary sensory afferents (Chen et al., 2012; Burnstock et al., 2011) . After lipopolysaccharide priming, P2X7 receptors release interleukin-1 in the spinal cord to cause mechanical hyperalgesia (Clark et al., 2010) . These findings agree with the recently reported intimate interaction between astrocytes/microglia and neurons in various areas of the CNS. Especially astrocytic 21 and neuronal networks may communicate by gliotransmitters such as ATP and glutamate (Fellin et al., 2006) , or cytokines, NO and ROS (Safiulina et al., 2006) .
In a very first series of experiments, we demonstrated by means of electrophysiological methods that SG astrocytes are endowed with functional P2X7
receptors, just like astrocytes in the cerebral cortex and hippocampal oriens layer (Nörenberg et al., 2010; Oliveira et al., 2011; Leichsenring et al., 2013) . Although we did not perform this time a detailed pharmacological analysis, a few findings unequivocally prove that we deal with P2X7 receptors at SG astrocytes: (1) A low X 2+ medium strongly accentuated the nucleotide-induced currents; (2) under these conditions, Bz-ATP was more potent than its mother compound ATP; and (3) the highly selective P2X7 receptor antagonist A-438079 almost abolished the effect of Bz-ATP (Sperlágh et al., 2006; Anderson and Nedergaard, 2006) . In addition, SG neurons also responded to Bz-ATP and ATP, exhibiting some differences from their astrocytic effects. In the first line, the Bz-ATP-induced neuronal currents had a larger scatter around the mean than the astrocytic ones. Moreover, ATP, in contrast to Bz-ATP caused only negligible current responses at SG neurons.
In view of the pertinent communication between astrocytes and neurons in various parts of the CNS, the question has arisen, whether the neuronal Bz-ATP/ATP effects are indirect, targeting originally astrocytes and transmitted to neurons by the release of a possible signaling molecule (Fellin et al., 2006; Safiulina et al., 2006) .
Specifically, P2X7 receptor activation at astroglia has been reported to release glutamate (Duan et al., 2003; Fellin et al., 2006) , GABA (Wirkner et al., 2005) and ATP itself (Suadicani et al., 2006) . By the use of selective antagonists for ionotropic glutamate (NMDA, AMPA) and GABA (GABA A ) receptors we demonstrated that the neuronal Bz-ATP responses were strongly inhibited, although usually not abolished.
By contrast, the corresponding astroglial responses remained unchanged in the presence of these antagonists. In addition, excised patches from most SG astrocytes continued to respond to Bz-ATP in an A-438079 antagonizable manner. Surprisingly, excised patches prepared from a subpopulation of SG neurons also retained an A- ROS, such as superoxide anion, hydrogen peroxide and hydroxyl radicals are cytotoxic agents released e.g. by the oxidative burst of microglia in response to its activation processes. In addition, considerable evidence suggests that these species are able to act as cellular signaling molecules to regulate biological functions (Adler et al., 1999 ). In the CNS, H 2 O 2 plays a role as an endogenous modulator of synaptic dopamine release (Chen et al., 2001) , participates in the manifestation of synaptic plasticity (Knapp and Klann, 2002) , and produces pain by reducing GABAergic inhibitory influence on SG neurons (Yowtak et al., 2011) .
Hence, it was interesting to observe that H 2 O 2 at a relatively low concentration of 100 M markedly increased the Bz-ATP current at SG neurons, without causing any change in SG astrocytes. Correspondingly, when given alone, the antioxidant Nacetyl-cysteine depressed the neuronal but not astrocytic response to Bz-ATP. Thus, the inactivation of endogenous ROS by N-acetyl-cysteine or the application of exogenous H 2 O 2 had opposite effects, supporting a possible reaction chain which involves the activation of astrocytic P2X7 receptors at astrocytes, the subsequent production of ROS and finally the potentiation of the neuronal AMPA and/or NMDA receptor-mediated cationic fluxes. The following findings favour such a mode of action: (1) we found that Bz-ATP increases the production/release of ROS from SG slices, probably by stimulating astroglial P2X7 receptors. (2) ATP induced the generation of ROS in hippocampal astrocytes, albeit by P2Y 1 and not P2X7 receptor stimulation, and increased the frequency of GABA A spontaneous synaptic currents in CA3 pyramidal neurons (Safiulina et al., 2006) . (3) ROS generated in Schwann cells 23 contributed to the ATP-mediated negative feed-back mechanism controlling the quantal secretion of acetylcholine from motor nerve terminals (Giniatullin et al., 2005) . (4) Eventually, it has been concluded that ROS or reactive nitrogen species react with the lipoprotein cell membrane and may thereby indirectly alter the function of ionotropic transmitter receptors (Stojilkovic et al., 2013) . A direct effect via the oxidation of critical cysteine residues (Cys-399 of the NR2A subunit, Choi and Lipton, 2000 ; Cys-430 of the P2X2 subunit; Coddou et al., 2009 ) at certain receptors of e.g.
the NMDA-or P2X-types is also possible.
At an early developmental stage ATP is definitely not the only, but probably the most powerful excitatory transmitter/signaling molecule in SG astrocytes. Astrocytes bear a number of pharmacological receptors including those for the excitatory amino acids glutamate (AMPA, NMDA) and the inhibitory amino acid GABA (GABA A ) (Verkhratsky and Steinhäuser, 2000; Lalo et al., 2011) . We found that AMPA and NMDA had larger effects in neurons than in astrocytes, whereas the GABA A receptor agonist muscimol had comparable activity to stimulate its neuronal and astrocytic receptors at a fixed concentration of 100 M. These findings are important in view of the well known excitotoxicity of glutamate and ATP exerted by the stimulation of ionotropic AMPA/NMDA and P2X7 receptors, respectively. In fact, the significance of these receptor-classes is increasingly recognized in stroke and neurodegenerative illnesses (Planells-Cases et al., 2006; Volonte et al., 2012; Köles et al., 2011) .
Similarly, they are involved in the spinal and supraspinal sensation of pain, especially in the case of neuronal damage (Bleakman et al., 2006; Planells-Cases et al., 2006; Burnstock et al., 2011) .
In a low X 2+ medium, CA1 hippocampal neurons also responded to Bz-ATP through P2X7 receptor-activation, in agreement with findings reported for astrocytes in the hippocampal oriens layer (Oliveira et al., 2011) . However, in the hippocampus, CA1
neurons did not possess P2X7 receptors; glutamate and GABA of astrocytic origin appeared to mediate the inward current response to Bz-ATP. Moreover, H 2 O 2 failed to potentiate the Bz-ATP effect on neurons and even depressed it on astrocytes in 24 this area of the brain. These are intriguing findings, since ATP has been shown previously to release ROS from astrocytes in the hippocampus, although by P2Y 1 rather than P2X7 receptor activation, and subsequently facilitated the spontaneous GABA release onto CA3 pyramidal neurons (Safiulina et al., 2006 Although the present evidence convincingly shows that P2X7 receptors are located at SG astrocytes and become unmasked in a low X 2+ medium to operate as a partner of SG neurons, the further participation of microglial P2X7 receptors as a third player on the stage cannot be excluded. The pathological function of microglia as a first defence barrier for all types of damage to the CNS is without question, but their roles in sensing and modulating neuronal activity as well as communicating with astrocytes has been only recently elucidated (Bezzi et al., 2001; Pascual et al., 2012) . Thus, in response to various stimuli, microglia are activated and they release small molecules such as nitric oxid, trophic factors, cytokines, and all types of neurotransmitters including ATP (Färber and Kettenmann, 2005) . Hence, microglia endowed with P2X7 receptors may react to ATP and release interleukin-1 or tumor necrosis factor- (Shieh et al., 2014) directly influencing SG neuronal activities; microglia could also release ATP (Imura et al., 2013) , which stimulates astrocytic P2X7 receptors and thereby induces a glutamate/GABA receptor-mediated interaction with the SG neurons.
In conclusion, we describe a P2X7 receptor-triggered interaction between astrocytes and neurons in the SG of the spinal cord dorsal horn. Under the present in vitro conditions this interaction operates only in a low Ca 2+ /no Mg 2+ medium. Such alterations in the ionic composition of the extracellular fluid may increase the susceptibility for neuronal discharges/seizures (Heinemann et al., 1992) known to depend on P2X7 receptors (Engel et al., 2012) and resembling the 25 aetiology/pathogenesis of neuropathic pain. Hence, in accordance with the general view that P2X7 receptors, due to their activation by large concentrations of endogenous ATP, function only under pathophysiological conditions (Sperlágh et al., 2006) , in the present study Bz-ATP/ATP caused rather small membrane currents in a normal external ionic milieu. performed in a similar manner as described for E and F. *P<0.05; statistically significant difference from the control current at S 2 . n.s.; no statistically significant difference between the two columns. 
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